Transplantation and Cellular Therapy
Publisher: Elsevier · ISSN 2666-6367 · 97 articles
- Severe graft-versus-host disease and limited durable response with mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma
- When cord blood grafts may be the preferred donor choice: a position statement from the ASTCT Cord Blood Special Interest Group
- Invasive fungal infections after moderate or severe chronic graft-versus-host disease in allogeneic hematopoietic cell transplant recipients: incidence, timing, and associated factors
- Model-informed precision dosing of busulfan in Adults: Real world implications for Dosing and Transplant outcomes
- Real-world access and barriers to CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a population-based study
- Comparison of pegfilgrastim and daily G-CSF for CD34+ cell mobilization in healthy donors and post-transplant engraftment: The Pegfilgrastim-23 Study
- A multicenter study of allogeneic HSCT in Nijmegen breakage syndrome with conditioning regimen based on reduced doses of treosulfan